Top accelerator startups

14,448 startups · 29 programs

SFA Therapeutics

Active · Regulating the immune system to block cancer & autoimmune diseases

8signal of 100 · rising 2
  • went through YCProgram · this site+4
  • team of 4Team size · YC's directory+3.6

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from S21 in AI

All of S21

About SFA Therapeutics

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
AI
Team size
4
Location
Philadelphia, PA, USA
Checked
7h ago

YC tags: AI-powered Drug Discovery, Anti-Aging, Biotech, Health & Wellness, Biotechnology

SFA Therapeutics in S21: 391 companies, 34% AI

SFA Therapeutics: questions

Which YC batch was SFA Therapeutics in?

SFA Therapeutics was in Y Combinator's Summer 2021 batch (S21).

Is SFA Therapeutics still active?

Y Combinator lists SFA Therapeutics as active.

Where is SFA Therapeutics based?

SFA Therapeutics lists Philadelphia, PA, USA as its location on YC's directory.